Heterogenous treatment effects: secrets for a reliable treat-to-target trial?
Cardiovasc Res
.
2017 Jun 1;113(7):e18-e20.
doi: 10.1093/cvr/cvx081.
Author
Tomasz J Guzik
1
2
Affiliations
1
Institute of Cardiovascular and Medical Sciences, University of Glasgow, Scotland, UK.
2
Department of Internal and Agricultural Medicine, Jagiellonian University, Collegium Medicum, ul. Skarbowa 1, 31-101, Krakow, Poland.
PMID:
28525917
PMCID:
PMC5852616
DOI:
10.1093/cvr/cvx081
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Blood Pressure
Randomized Controlled Trials as Topic
Grants and funding
FS/14/49/30838/BHF_/British Heart Foundation/United Kingdom
RE/13/5/30177/BHF_/British Heart Foundation/United Kingdom